№ lp_1_2_29861
File format: docx
Character count: 56471
File size: 150 KB
This document provides detailed information about a pharmaceutical product, including dosage, administration instructions, warnings, precautions, and clinical information for healthcare professionals, as well as specific instructions for drugs authorized under the NOC/c policy.
Note:
Year
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2023
Region / city:
United States
Subject:
Health Information Technology, Healthcare Management
Document Type:
Monograph
Organization:
Department of Veterans Affairs
Author:
Health Product Support
Target Audience:
Veterans Health Administration (VHA) staff, healthcare professionals, and IT personnel
Effective Period:
Ongoing
Approval Date:
July 18, 2023
Revision Date:
July 18, 2023
Year:
2023
Region / city:
Wales
Topic:
Healthcare, Pharmaceutical Services, Urinary Tract Infections
Document Type:
Consultation Document
Organization / Institution:
AWTTC (All Wales Therapeutic and Toxicology Centre)
Author:
Alwyn Fortune
Target Audience:
Healthcare professionals, pharmacists, public health authorities
Effective Period:
Until consultation closing date
Approval Date:
Not provided
Amendment Date:
Not provided
Generic name:
Hydrocodone extended-release
Trade name:
Zohydro ER®
Dosage form:
Extended-release capsules
Manufacturer:
Pernix Ireland Pain Limited
NDCs:
43376-310-60; 43376-315-60; 43376-320-60; 43376-330-60; 43376-340-60; 43376-350-60
Regulatory authority:
U.S. Food and Drug Administration
FDA approval:
2013; reformulated version approved January 2015
Indication:
Severe pain requiring around-the-clock, long-term opioid treatment when alternatives are inadequate
Administration:
Twice daily
Initial dosing:
10 mg every 12 hours in opioid-naïve patients
Dose titration:
Increments of 10 mg every 12 hours every 3–7 days
Maximum dose:
Not established
Abuse-deterrent status:
Not originally abuse-deterrent; reformulated with BeadTek™ technology
Risk management:
Subject to class-wide REMS requirements for extended-release/long-acting opioids
Clinical evidence:
12-week randomized, double-blind, placebo-controlled trials in chronic low back pain
Jurisdictional consideration:
Evaluated for inclusion on the Massachusetts formulary under Chapter 258 of the Acts of 2014
Regulatory actions:
Massachusetts dispensing ban via executive order prior to reformulation
Year:
2012
Type of document:
Instructional guide
Subject:
Research writing and journal publication process
Publishing Partner:
IJSRP Inc
Copyright:
Copyright©2012, All Rights Reserved
Intended audience:
Research scholars and authors
Scope:
Preparation, review, and publication of research papers and monographs
Review process:
Peer review with reviewer comments within 10–15 days
Publication format:
Online and printed periodicals
Software mentioned:
Matlab
Sections included:
Preface; Introduction; Identification and Research; Writing Studies and Findings; Reviewer Improvements; Conclusion; Appendixes; Glossary; Index
Intellectual property:
Authors retain copyright ownership
Year:
2026
Region / City:
Germany
Subject:
Analytical Chemistry / Cannabis Testing
Document Type:
Laboratory Method / Standard Operating Procedure
Institution:
In-house Laboratory
Author:
Laboratory Personnel
Target Audience:
Trained Analytical Staff
Applicable Period:
Until Method Revision
Approval Date:
2026-03-17
Revision Date:
N/A
Materials:
CBD and THCA standards, methanol, acetonitrile, vanillin, acids, ethanol, water, TLC plates, filters
Equipment:
Analytical balance, grinder, sieve, sonicator, oven, syringes
Method Verification:
MVR-005 (G-0043) Cannabis Flowers German Monograph Verification Report
Year:
2021
Region / City:
Canberra
Topic:
Medication Safety
Document Type:
Policy Statement
Organization / Institution:
Canberra Health Services
Author:
Not specified
Target Audience:
CHS staff, including employees, contractors, volunteers, and students
Effective Period:
Indefinite
Approval Date:
12/05/2021
Amendment Date:
12/05/2021
Year:
2006
Region / City:
Australia
Topic:
Medication management, disability services
Document Type:
Legal / Regulatory
Organization:
Disability Services
Author:
Not specified
Target Audience:
Healthcare providers, professionals in disability services
Effective Period:
Ongoing
Approval Date:
Not specified
Amendment Date:
Not specified
Year:
2016
Region / City:
Glendale, CO
Subject:
Medication Bubble Wrap Services for Veterans Affairs
Document Type:
Presolicitation Notice
Agency / Institution:
Department of Veterans Affairs
Author:
Robert Woolfolk
Target Audience:
Contractors, Veteran-Owned Businesses, and Small Businesses
Start Date:
15 Feb 2016
Contract Duration:
1 base year with 4 one-year options and 1 six-month extension
Approval Date:
January 2016
Amendment Date:
Not specified
NAICS Code:
446110
Service Location:
VHASLCHCS Outpatient Pharmacy, Salt Lake City, UT
Description:
Pre-solicitation notice for medication bubble packaging services at Veterans Affairs facilities, detailing contract terms, scope, and bidding process.
Year:
2022-2023
Region / City:
Not specified
Topic:
Medication safety best practices in hospitals
Document Type:
Best practices guide
Organization / Institution:
ISMP
Author:
ISMP
Target Audience:
Healthcare professionals, hospital administrators
Period of Validity:
2022-2023
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2014
Region / City:
United States
Topic:
Medication Administration, Medical Authorization
Document Type:
Authorization Form
Organization / Institution:
245D licensed program
Author:
Not specified
Target Audience:
Individuals receiving medication assistance, legal representatives
Period of Validity:
Ongoing
Approval Date:
January 1, 2014
Date of Changes:
Not specified
Year:
2014
Note:
Program name
Year:
2025
Region / City:
Massachusetts, Boston
Topic:
Healthcare, Opioid Use Disorder, Long-Term Care
Document Type:
Memorandum
Organization / Institution:
Department of Public Health
Author:
Teryl Smith, RN, MPH
Target Audience:
Long-Term Care Facility Administrators
Period of Validity:
August 14, 2025
Approval Date:
August 14, 2025
Date of Changes:
August 14, 2025
Year:
2025
Region / City:
Maine
Topic:
Implementation Reviewer for Child Welfare Psychotropic Medication
Document Type:
Request for Proposals (RFP)
Agency / Institution:
Maine Department of Health and Human Services, Office of Child and Family Services
Author:
Casandra Manson
Target Audience:
Potential bidders for the RFP
Validity Period:
Until September 16, 2025
Approval Date:
August 2025
Amendment Date:
None provided
Year:
2023
Region / City:
Not specified
Topic:
Medication administration via G or J Tube
Document Type:
Training Guidelines
Organization / Institution:
Not specified
Author:
Not specified
Target Audience:
Certified staff and trainers
Effective Period:
Not specified
Approval Date:
Not specified
Date of Amendments:
Not specified
Description:
A document outlining the general knowledge and competencies required for administering medication through a Gastrostomy (G) or Jejunostomy (J) Tube, aimed at healthcare professionals.
Year:
2024
Region / City:
North Carolina
Theme:
Medication Assistance, Rural Health
Document Type:
FAQ
Organization / Institution:
North Carolina Office of Rural Health
Author:
North Carolina Office of Rural Health
Target Audience:
Organizations providing health services to underserved and medically indigent populations
Period of Effectiveness:
2024-2025
Approval Date:
Not specified
Amendment Date:
Not specified
Year:
2022
Region / City:
Massachusetts
Subject:
Opioid Use Disorder, Long-Term Care Facilities
Document Type:
Memorandum
Agency:
Massachusetts Executive Office of Health and Human Services, Department of Public Health
Author:
Elizabeth Kelley, MPH, MBA, Director Bureau of Health Care Safety and Quality
Target Audience:
Long-Term Care Facility Administrators
Period of Validity:
September 12, 2022
Approval Date:
September 12, 2022
Year:
2023
Region / City:
Falkirk
Theme:
Health & Social Care, Pharmacy, Medication Management
Document Type:
Policy
Organization:
Falkirk Health & Social Care Partnership
Author:
Not specified
Target Audience:
Community pharmacies, care at home providers, healthcare professionals
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified